News and Announcements
QBiotics Share Offer Oversubscribed by $4.3m
- Published October 12, 2016 3:30PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Long term Axstra client QBiotics Limited has successfully raised in $16.8 million from its latest round of capital raising. The Company’s Prospectus Share Offer was oversubscribed by $4.3m following high demand from investors. In light of the interest in QBiotics, a Private Placement was also successfully implemented.
The new capital places QBiotics in a strong financial position moving forward with over AU$30 million in the bank. Current emphasis is on finalising product development and market launch preparation of the anticancer drug EBC-46 for the USA and UK veterinary market, and development of QBiotics’ wound healing treatment WH-1 for human diabetic foot ulcers and venous leg ulcers.